A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
- PMID: 1840703
- DOI: 10.1126/science.1840703
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
Abstract
Many human melanoma tumors express antigens that are recognized in vitro by cytolytic T lymphocytes (CTLs) derived from the tumor-bearing patient. A gene was identified that directed the expression of antigen MZ2-E on a human melanoma cell line. This gene shows no similarity to known sequences and belongs to a family of at least three genes. It is expressed by the original melanoma cells, other melanoma cell lines, and by some tumor cells of other histological types. No expression was observed in a panel of normal tissues. Antigen MZ2-E appears to be presented by HLA-A1; anti-MZ2-E CTLs of the original patient recognized two melanoma cell lines of other HLA-A1 patients that expressed the gene. Thus, precisely targeted immunotherapy directed against antigen MZ2-E could be provided to individuals identified by HLA typing and analysis of the RNA of a small tumor sample.
Republished in
-
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.J Immunol. 2007 Mar 1;178(5):2617-21. J Immunol. 2007. PMID: 17312099 No abstract available.
Similar articles
-
Perspectives for immunization of HLA-A1 patients carrying a malignant melanoma expressing gene MAGE-1.Dermatology. 1993;186(4):278-80. doi: 10.1159/000247375. Dermatology. 1993. PMID: 8513199
-
A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.J Exp Med. 1995 Sep 1;182(3):689-98. doi: 10.1084/jem.182.3.689. J Exp Med. 1995. PMID: 7544395 Free PMC article.
-
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.J Exp Med. 1994 Mar 1;179(3):921-30. doi: 10.1084/jem.179.3.921. J Exp Med. 1994. PMID: 8113684 Free PMC article.
-
Genes coding for tumor antigens recognized by human cytolytic T lymphocytes.J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):104-9. doi: 10.1097/00002371-199308000-00004. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8280701 Review.
-
Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy.Int J Cancer. 1993 May 8;54(2):177-80. doi: 10.1002/ijc.2910540202. Int J Cancer. 1993. PMID: 8486420 Review. No abstract available.
Cited by
-
Prognostic Value of Melanoma-Associated Antigen-A (MAGE-A) Gene Expression in Various Human Cancers: A Systematic Review and Meta-analysis of 7428 Patients and 44 Studies.Mol Diagn Ther. 2020 Oct;24(5):537-555. doi: 10.1007/s40291-020-00476-5. Mol Diagn Ther. 2020. PMID: 32548799 Free PMC article.
-
How the Intrinsically Disordered N-Terminus of Cancer/Testis Antigen MAGEA10 Is Responsible for Its Expression, Nuclear Localisation and Aberrant Migration.Biomolecules. 2023 Nov 24;13(12):1704. doi: 10.3390/biom13121704. Biomolecules. 2023. PMID: 38136576 Free PMC article.
-
Unbiased identification of target antigens of CD8+ T cells with combinatorial libraries coding for short peptides.Nat Med. 2012 May;18(5):824-8. doi: 10.1038/nm.2720. Nat Med. 2012. PMID: 22484809
-
Releasing the brakes to fight cancer: The recent discovery of checkpoints has boosted the field of cancer immunotherapy.EMBO Rep. 2016 Sep;17(9):1257-60. doi: 10.15252/embr.201643038. Epub 2016 Jul 25. EMBO Rep. 2016. PMID: 27458238 Free PMC article. Review.
-
Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens.J Biomed Sci. 2024 Oct 9;31(1):94. doi: 10.1186/s12929-024-01082-x. J Biomed Sci. 2024. PMID: 39379923 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials